Neratinib
Back to searchMolecule Structure
Scientific Name
Neratinib
Description of the Drug
Neratinib is a protein kinase inhibitor used to treat breast cancer that over expresses the HER2 receptor.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11828
http://www.drugbank.ca/drugs/DB11828
Brand Name(s)
Not Available
Company Owner(s)
Puma Biotechnology Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Receptor protein-tyrosine kinase erbB-2 | SINGLE PROTEIN | INHIBITOR | CHEMBL1824 |
| Receptor protein-tyrosine kinase erbB-4 | SINGLE PROTEIN | INHIBITOR | CHEMBL3009 |
| Epidermal growth factor receptor erbB1 | SINGLE PROTEIN | INHIBITOR | CHEMBL203 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL571762 | ||
| DrugBank | DB11828 | ||
| PubChem: Thomson Pharma | 14886227 | ||
| PubChem | 9915743 | ||
| LINCS | LSM-42778 | ||
| Nikkaji | J2.688.659G | ||
| BindingDB | 50161957 | ||
| EPA CompTox Dashboard | DTXSID70220132 | ||
| DrugCentral | 5252 | ||
| Brenda | 213554 | ||
| ChemicalBook | CB2855051 | ||
| Guide to Pharmacology | 5686 | ||
| rxnorm | NERLYNX | NERATINIB | NERATINIB MALEATE |
| PubChem: Drugs of the Future | 123055351 | ||
| ChEBI | 61397 | ||
| ZINC | ZINC000003916214 |
